Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.89
0.00 (0.00%)
Oct 5, 2026, 4:00 PM EDT - Market closed
DMAA Market Cap
DMAA has a market cap or net worth of $264.38 million as of October 5, 2026. Its market cap has decreased by -23.20% in one year.
Market Cap
264.38M
Enterprise Value
264.71M
1-Year Change
-23.20%
Ranking
Category
Stock Price
$10.89
ChartMarket Cap Chart
Since the IPO on January 28, 2025, DMAA's market cap has decreased from $291.71M to $264.38M, a decrease of -9.37%. That is a compound annual growth rate of -5.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 264.38M | -23.97% |
| Dec 30, 2025 | 347.71M | 19.20% |
| Jan 28, 2025 | 291.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cantor Equity Partners I | 274.13M |
| Muzero Acquisition | 273.48M |
| Dynamix Corporation III | 270.48M |
| Karman Line Acquisition | 267.70M |
| Catalyst Acquisition | 266.27M |
| Oaktree Acquisition Corp. III Life Sciences | 264.51M |
| FACT II Acquisition | 260.73M |
| Newbury Street II Acquisition | 260.70M |